Nano-flower-stick composite structure S-scheme Au/MoS2/Bi2S3 heterojunction with multiple enzyme-like activity for efficient tumor photothermal and photodynamic combination therapy
Source abstract
Abstract
• An S-scheme Au/MoS 2 /Bi 2 S 3 heterojunction with multi-enzyme activities was innovatively designed for enhanced photothermal and photodynamic tumor therapy. • This novel nano-catalyst effectively overcame the tumor microenvironment’s resistance by synergistically generating reactive oxygen species and depleting glutathione through PTT/PDT. • Photoactivated Au/MoS 2 /Bi 2 S 3 significantly suppressed tumor growth and promoted apoptosis, offering superior efficacy and excellent biological safety in both in vitro and in vivo models. Nano-catalytic therapy mediated by reactive oxygen species (ROS) is a highly promising tumor treatment strategy. However, the unique physiological and biochemical characteristics of tumor microenvironment, such as hypoxia and overexpression of antioxidants and glutathione, limit the production of ROS and their oxidation capacity within the tumor. In this study, an S-scheme heterojunction (Au/MoS 2 /Bi 2 S 3 ) with multiple enzyme activities was constructed to achieve significant anti-tumor effects through photothermal/photodynamic combination therapy (PTT/PDT). Under near infra-red irradiation, Au/MoS 2 /Bi 2 S 3 heterojunction not only provided high fever for PTT but also generated singlet oxygen for PDT. In addition, the Au/MoS 2 /Bi 2 S 3 heterojunction also could generate H 2 O 2 in-situ (Glucose oxidase-like activity), meanwhile simultaneously complete the decomposition of endogenous H 2 O 2 (Peroxidase-like and Catalase-like activity) and depletion of glutathione (Glutathione-peroxidase-like activity) through the conversion between Mo 4+ and Mo 6+ , further enhancing the generation of ROS. In vitro and in vivo studies demonstrated that the photoactivated Au/MoS 2 /Bi 2 S 3 heterojunction, with its multiple enzyme-like activities, could effectively achieve tumor regression within the observation period while also exhibiting high biological safety. This study provided a new perspective for tumor therapy based on nano-catalytic method.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Advanced Photocatalysis Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Hosmane · 2012
2. The pleiotropic functions of reactive oxygen species in cancer10.1038/s43018-024-00738-9 ↗
3. Reactive Oxygen-Primed and Autophagy Inhibition-Sensitized Ferroptosis combined with Photothermal Ablation for Tumor Therapy10.1021/acsmaterialslett.3c00536 ↗
4. Defect Engineering in Biomedical Sciences10.1002/adma.202304176 ↗
5. Tumor-Generated Reactive Oxygen Species storm for High-Performance Ferroptosis Therapy10.1021/acsnano.3c01369 ↗
6. Reactive Oxygen Species Amplifier for Apoptosis-Ferroptosis Mediated High-Efficiency Radiosensitization of Tumors10.1021/acsnano.4c01625 ↗
7. A pH/GSH/Glucose Responsive Nanozyme for Tumor Cascade Amplified Starvation and Chemodynamic Theranostics10.1021/acsami.3c05412 ↗
8. Nanozymes: Versatile Platforms for Cancer Diagnosis and Therapy10.1007/s40820-022-00828-2 ↗
9. Boron in cancer therapeutics: an overview10.1016/j.pharmthera.2023.108548 ↗
10. Inherent Tumor Microenvironment-reversing Hydrogels: Potentiating Molecular Therapy Efficacy against Drug-Resistant Tumors10.1002/adfm.202314772 ↗
11. Nanomedicine-Enabled Chemical Regulation of Reactive X Species for Versatile Disease Treatments10.1002/anie.202309160 ↗
12. Donor-Acceptor Type Supra-Carbon-Dots with Long Lifetime Photogenerated Radicals Boosting Tumor Photodynamic Therapy10.1002/anie.202410522 ↗
13. Plasma Membrane Targeted Photodynamic Nanoagonist to Potentiate Immune Checkpoint Blockade Therapy by Initiating Tumor Cell Pyroptosis and Depleting Infiltrating B Cells10.1002/adma.202415078 ↗
14. Tumor-activated in situ synthesis of single-atom catalysts for O-independent photodynamic therapy based on water-splitting10.1038/s41467-024-46987-1 ↗
15. Tumor microenvironment-responsive nanosystem achieves reactive oxygen species self-cycling after photothermal induction to enhance efficacy of antitumor therapy10.1016/j.cej.2023.142370 ↗
16. Enzyme-activated nanomaterials for MR imaging and tumor therapy10.1016/j.ccr.2024.215842 ↗
17. Ultrasmall metal alloy nanozymes mimicking neutrophil enzymatic cascades for tumor catalytic therapy10.1038/s41467-024-45668-3 ↗
18. Photocatalytic Superoxide Radical Generator that Induces Pyroptosis in Cancer Cells10.1021/jacs.2c03256 ↗
19. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology10.1038/s41580-022-00456-z ↗
20. Type-I organic photosensitizers with two complementary reactive oxygen species based on donor-acceptor (D-A) molecules10.1016/j.dyepig.2023.111444 ↗
21. Wirelessly Activated Nanotherapeutics for In Vivo Programmable Photodynamic-Chemotherapy of Orthotopic Bladder Cancer10.1002/advs.202200731 ↗
22. Building Ultrathin MOL/MOL S-Scheme Heterostructures toward Boosted Photocatalytic Charge Kinetics for Efficient H Evolution10.1002/anie.202502009 ↗
23. Synergistic Enhancement of Photocatalytic CO Reduction by Built-in Electric Field/Piezoelectric effect and Surface Plasmon Resonance via PVDF/CdS/Ag Heterostructure10.1002/smll.202304202 ↗
24. Oxygen-Independent synchronized ROS Generation and Hypoxia Prodrug Activation with Z-Scheme Heterostructure Sonosensitizer10.1002/adma.202307929 ↗
25. Reshaping the Tumor Immune Microenvironment based on a Light-Activated Nanoplatform for Efficient Cancer Therapy10.1002/adma.202108908 ↗
26. Heterojunction Photocatalysts10.1002/adma.201601694 ↗
27. Twin S-Scheme g-C3N4/CuFe2O4/ZnIn2S4 Heterojunction with a Self-supporting Three-phase System for Photocatalytic CO2 Reduction: Mechanism Insight and DFT Calculations10.1021/acscatal.4c00409 ↗
28. Highly Selective Photoelectroreduction of Carbon Dioxide to Ethanol over Graphene/Silicon Carbide Composites10.1002/anie.202218664 ↗
29. S-scheme heterojunction photocatalysts based on 2D materials10.1016/j.mattod.2024.10.006 ↗
30. Integration of Fe3O4 with Bi2S3 for multi-modality tumor theranostics10.1021/acsami.0c05088 ↗
31. Photocatalytic self-Fenton degradation of ciprofloxacin over S-scheme CuFe2O4/ZnIn2S4 heterojunction: Mechanism insight, degradation pathways and DFT calculations10.1016/j.cej.2024.149165 ↗
32. MoS2-based nanocomposites for cancer diagnosis and therapy
33. A Multifunctional Layered Nickel Silicate Nanogenerator of Synchronous Oxygen Self-supply and Superoxide Radical Generation for Hypoxic Tumor Therapy10.1021/acsnano.1c08580 ↗
34. A Purposefully Designed pH/GSH-Responsive MnFe-Based Metal-Organic Frameworks as Cascade Nanoreactor for Enhanced Chemo-Chemodynamic-Starvation Synergistic Therapy10.1002/smll.202303403 ↗
35. Tensile Strain-Mediated Bimetallene Nanozyme for Enhanced Photothermal Tumor Catalytic Therapy10.1002/anie.202403203 ↗
36. Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer
37. PRMT5 regulates epigenetic changes in suppressive Th1-like iTregs in response to IL-12 treatment10.3389/fimmu.2023.1292049 ↗
38. Obtaining Ligand-Free Aqueous Au-Nanoparticles using Reversible CsPbBr ⇆ Au@CsPbBr Nanocrystal Transformation10.1002/smll.202311712 ↗
39. Electronic Modulation and Built-in Electric Field strategies in Heterostructures together Induce 1T-rich MoS Conversion for Advanced Sodium Storage10.1002/advs.202417288 ↗
40. Edge modification facilitated heterogenization and exfoliation of two-dimensional nanomaterials for cancer catalytic therapy10.1126/sciadv.abo7372 ↗
41. BiOBr/MXene/gC3N4 Z-scheme heterostructure photocatalysts mediated by oxygen vacancies and MXene quantum dots for tetracycline degradation: Process, mechanism and toxicity analysis10.1016/j.apcatb.2022.122150 ↗
42. Enhanced electro-Fenton catalytic performance with in-situ grown Ce/Fe@NPC-GF as self-standing cathode: Fabrication, influence factors and mechanism10.1016/j.chemosphere.2021.130269 ↗
43. Interfacial Chemical Bond Engineering in a Direct Z-Scheme g-C3N4/ MoS2 Heterojunction10.1021/acsami.2c21046 ↗
44. Plasmon Ag/Na-doped defective graphite carbon nitride/NiFe layered double hydroxides Z-scheme heterojunctions toward optimized photothermal-photocatalytic-Fenton performance10.1016/j.apcatb.2021.120969 ↗
45. A facile reflux method for in situ fabrication of a non-cytotoxic Bi2S3/β-Bi2O3/ZnIn2S4 ternary photocatalyst: a novel dual Z-scheme system with enhanced multifunctional photocatalytic activity10.1039/D0TA06129H ↗
46. Cooperative coupling strategy for constructing 0D/2D carbon nitride composites with strengthened chemical interaction for enhanced photocatalytic applications10.1016/j.cej.2021.134075 ↗
47. Synergizing Catalysis with Post-catalysis Pseudo-Iron Release by Building Dynamic Catalytic active Sites in Diatomic Nanozymes for Boosting Cancer Therapy10.1021/jacs.5c03804 ↗
48. Enhancing Peroxidase-like activity and Photothermal Property of Copper Single-Atom Nanozyme via a Cascade Competition strategy10.1002/adfm.202422588 ↗
49. Adipocyte-derived glutathione promotes obesity-related breast cancer by regulating the SCARB2-ARF1-mTORC1 complex10.1016/j.cmet.2024.09.013 ↗
50. Synchronously Evoking Disulfidptosis and Ferroptosis via Systematical Glucose Deprivation Targeting SLC7A11/GSH/GPX4 Antioxidant Axis10.1021/acsnano.5c00730 ↗
51. Emerging role of NRF2 in ROS-mediated tumor chemoresistance10.1016/j.biopha.2020.110676 ↗
52. Cell-Type-Dependent Recruitment Dynamics of FUS Protein at Laser-Induced DNA damage Sites10.3390/ijms25063526 ↗
53. Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours10.15252/emmm.202114501 ↗
54. Transcriptomic Analysis reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma10.3390/ijms24043148 ↗
55. Identification of the prognostic and therapeutic values of cyclin E1 (CCNE1) gene expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: a database mining approach10.1016/j.heliyon.2022.e10367 ↗
56. Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis10.1136/gutjnl-2022-327608 ↗
57. STK11/LKB1 Modulation of the Immune Response in Lung Cancer: from Biology to Therapeutic Impact10.3390/cells10113129 ↗
58. NIR-Actuated Ferroptosis Nanomotor for Enhanced Tumor Penetration and Therapy
59. Flexocatalytic Reduction of Tumor Interstitial Fluid/Solid pressure for Efficient Nanodrug Penetration
60. Tuning of the Aggregation Behavior of Fluorinated Polymeric Nanoparticles for improved Therapeutic Efficacy10.1021/acsnano.0c02954 ↗
61. Molybdenum - a scoping review for Nordic Nutrition Recommendations 202310.29219/fnr.v67.10326 ↗
62. Molecular Insights into Bismuth's New applications against Antimicrobial Resistance and Coronaviruses10.1021/acs.accounts.5c00471 ↗